RE: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer Response

被引：0
|
作者：
Wang, Xinan [1 ,2 ]
Ricciuti, Biagio [3 ,4 ]
Alessi, Joao, V [3 ,4 ]
Nguyen, Tom [3 ,4 ]
Awad, Mark M. [3 ,4 ]
Lin, Xihong [5 ]
Johnson, Bruce E. [3 ,4 ]
Christiani, David C. [2 ,6 ]
机构：
[1] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA
[2] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 667 Huntington Ave, Boston, MA 02115 USA
[3] Harvard Med Sch, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA
[4] Harvard Med Sch, Ctr Canc Gen, Dana Farber Canc Inst, Boston, MA USA
[5] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[6] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2022年 / 114卷 / 03期
关键词：
D O I：
10.1093/jnci/djab161
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：477 / 478
页数：2
相关论文
共 50 条
  • [21] Mining metastatic lymph nodes for response to immune checkpoint therapy in non-small cell lung cancer
    Donders, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S271 - S271
  • [22] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [23] Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non-small cell lung cancer
    Sun, Li-Yue
    Cen, Wen-Jian
    Tang, Wen-Ting
    Long, Ya-Kang
    Yang, Xin-Hua
    Ji, Xiao-Meng
    Yang, Jiao-Jiao
    Zhang, Ren-Jing
    Wang, Fang
    Shao, Jian-Yong
    Du, Zi-Ming
    CANCER MEDICINE, 2021, 10 (19): : 6610 - 6617
  • [24] iSEND Model as a Predictor of Efficacy in Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer: Fukushima Cohort
    Okabe, N.
    Mine, H.
    Takagi, H.
    Watanabe, M.
    Muto, S.
    Hasegawa, T.
    Shio, Y.
    Park, W.
    Lopes, G.
    Suzuki, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S935 - S935
  • [25] Splenic Volume as a Surrogate Marker of Immune Checkpoint Inhibitor Efficacy in Metastatic Non Small Cell Lung Cancer
    Galland, Loick
    Lecuelle, Julie
    Favier, Laure
    Fraisse, Clea
    Lagrange, Aurelie
    Kaderbhai, Coureche
    Truntzer, Caroline
    Ghiringhelli, Francois
    CANCERS, 2021, 13 (12)
  • [26] Immuno-PET in predicting immune checkpoint inhibitor response in non-small cell lung cancer
    Silva, S. G.
    Amorim, D.
    Feijo, S.
    Barata, F. J.
    Figueiredo, A. M.
    Hrynchak, I.
    Silva, M.
    Moreira, A. P.
    Abrunhosa, A.
    Cordeiro, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S148 - S148
  • [27] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
    Takeuchi, Eiji
    Kondo, Kensuke
    Okano, Yoshio
    Kunishige, Michihiro
    Kondo, Yoshihiro
    Kadota, Naoki
    Machida, Hisanori
    Hatakeyama, Nobuo
    Naruse, Keishi
    Ogino, Hirokazu
    Nokihara, Hiroshi
    Shinohara, Tsutomu
    Nishioka, Yasuhiko
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3139 - 3147
  • [28] Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study
    Ziyi Xu
    Xuezhi Hao
    Ke Yang
    Qi Wang
    Jing Wang
    Lin Lin
    Fei Teng
    Junling Li
    Puyuan Xing
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 3081 - 3089
  • [29] Immune checkpoint inhibitor rechallenge in advanced or metastatic non-small cell lung cancer: a retrospective cohort study
    Xu, Ziyi
    Hao, Xuezhi
    Yang, Ke
    Wang, Qi
    Wang, Jing
    Lin, Lin
    Teng, Fei
    Li, Junling
    Xing, Puyuan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3081 - 3089
  • [30] Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
    Eiji Takeuchi
    Kensuke Kondo
    Yoshio Okano
    Michihiro Kunishige
    Yoshihiro Kondo
    Naoki Kadota
    Hisanori Machida
    Nobuo Hatakeyama
    Keishi Naruse
    Hirokazu Ogino
    Hiroshi Nokihara
    Tsutomu Shinohara
    Yasuhiko Nishioka
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3139 - 3147
12345